Dr TUNG Kwok Kwan, Edmund | edmund@pathology.hku.hk
PhD HK

Awards and Honors

AACR-ITO EN, Ltd. Scholar-in-Training Award (2007)

Recent Publication Lists

Wong CC, Wong CM, Tung EK, Man K, Ng IO. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology 2009;49:1583-1594.

Tung EK, Wong CM, Yau TO, Lee JM, Ching YP, Ng IO. HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions. Int J Cancer 2009;124:1811-1819.

Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 2007;45:1129-1138.

Yam JW, Ko FC, Chan CY, Yau TO, Tung EK, Leung TH, Jin DY, Ng IO. Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma. Hepatology 2006;44:881-890.

Tung EK, Choi RC, Siow NL, Jiang JX, Ling KK, Simon J, Barnard EA, Tsim KW. P2Y2 receptor activation regulates the expression of acetylcholinesterase and acetylcholine receptor genes at vertebrate neuromuscular junctions. Mol Pharmacol 2004;66:794-806.

Tsim KW, Choi RC, Siow NL, Cheng AW, Ling KK, Jiang JX, Tung EK, Lee HH, Xie QH, Simon J, Barnard EA. ATP induces post-synaptic gene expressions in vertebrate skeletal neuromuscular junctions. J Neurocytol 2003;32:603-617.

Choi RC, Siow NL, Cheng AW, Ling KK, Tung EK, Simon J, Barnard EA, Tsim KW. ATP acts via P2Y1 receptors to stimulate acetylcholinesterase and acetylcholine receptor expression: transduction and transcription control. J Neurosci 2003;23:4445-4456.

Cheng AW, Kong LW, Tung EK, Siow NL, Choi RC, Zhu SQ, Peng BH, Tsim KW. cDNA encodes Xenopus P2Y(1) nucleotide receptor: expression at the neuromuscular junctions. Neuroreport 2003;14:351-357.